Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David R Liu

Showing results (271-280 of 321) with videos related to

Pageof 33
Sort By:
Nature Biotechnology|May 21, 2026
AI-guided redesign of laboratory-evolved reverse transcriptases enhances prime editingY Allen Tao, Holt A Sakai, Allen Y Jiang, et al.
American Journal of Human Genetics|April 2, 2026
Implications of the FDA's new plausible mechanism framework for the development of a personalized in vivo prime editing platformEmily R Feierman, Madelynn N Whittaker, Aidan Quigley, et al.
Science (New York, N.Y.)|March 30, 2023
Base editing rescue of spinal muscular atrophy in cells and in miceMandana Arbab, Zaneta Matuszek, Kaitlyn M Kray, et al.
Cell|September 1, 2023
Phage-assisted evolution and protein engineering yield compact, efficient prime editorsJordan L Doman, Smriti Pandey, Monica E Neugebauer, et al.
Biorxiv : the Preprint Server for Biology|March 22, 2023
A molecular glue approach to control the half-life of CRISPR-based technologiesVedagopuram Sreekanth, Max Jan, Kevin T Zhao, et al.
Science (New York, N.Y.)|May 15, 2025
Programmable gene insertion in human cells with a laboratory-evolved CRISPR-associated transposaseIsaac P Witte, George D Lampe, Simon Eitzinger, et al.
Nature Biotechnology|June 15, 2023
Adenine transversion editors enable precise, efficient A•T-to-C•G base editing in mammalian cells and embryosLiang Chen, Mengjia Hong, Changming Luan, et al.
Nature Biotechnology|April 24, 2024
Author Correction: Adenine transversion editors enable precise, efficient A•T-to-C•G base editing in mammalian cells and embryosLiang Chen, Mengjia Hong, Changming Luan, et al.
Nature Biotechnology|July 15, 2025
Platform solutions for commercial challenges to expanding patient access and making gene editing sustainableSadik H Kassim, Fyodor Urnov, Kiran Musunuru, et al.
Blood Advances|October 28, 2025
Comparative Analysis of CRISPR-Cas9, lentiviral transduction, and base editing for sickle cell disease in a murine modelHenna Butt, Shruti Sathish, Evan London, et al.
Pageof 33

Showing results (271-280 of 321) with videos related to

Sort By:
Pageof 33
Nature Biotechnology|May 21, 2026
AI-guided redesign of laboratory-evolved reverse transcriptases enhances prime editingY Allen Tao, Holt A Sakai, Allen Y Jiang, et al.
American Journal of Human Genetics|April 2, 2026
Implications of the FDA's new plausible mechanism framework for the development of a personalized in vivo prime editing platformEmily R Feierman, Madelynn N Whittaker, Aidan Quigley, et al.
Science (New York, N.Y.)|March 30, 2023
Base editing rescue of spinal muscular atrophy in cells and in miceMandana Arbab, Zaneta Matuszek, Kaitlyn M Kray, et al.
Cell|September 1, 2023
Phage-assisted evolution and protein engineering yield compact, efficient prime editorsJordan L Doman, Smriti Pandey, Monica E Neugebauer, et al.
Biorxiv : the Preprint Server for Biology|March 22, 2023
A molecular glue approach to control the half-life of CRISPR-based technologiesVedagopuram Sreekanth, Max Jan, Kevin T Zhao, et al.
Science (New York, N.Y.)|May 15, 2025
Programmable gene insertion in human cells with a laboratory-evolved CRISPR-associated transposaseIsaac P Witte, George D Lampe, Simon Eitzinger, et al.
Nature Biotechnology|June 15, 2023
Adenine transversion editors enable precise, efficient A•T-to-C•G base editing in mammalian cells and embryosLiang Chen, Mengjia Hong, Changming Luan, et al.
Nature Biotechnology|April 24, 2024
Author Correction: Adenine transversion editors enable precise, efficient A•T-to-C•G base editing in mammalian cells and embryosLiang Chen, Mengjia Hong, Changming Luan, et al.
Nature Biotechnology|July 15, 2025
Platform solutions for commercial challenges to expanding patient access and making gene editing sustainableSadik H Kassim, Fyodor Urnov, Kiran Musunuru, et al.
Blood Advances|October 28, 2025
Comparative Analysis of CRISPR-Cas9, lentiviral transduction, and base editing for sickle cell disease in a murine modelHenna Butt, Shruti Sathish, Evan London, et al.
Pageof 33